Elizabeth A. Eisenhauer

Research interests

Publications

• Evolution of the Randomized Clinical Trial in the Era of Precision Oncology

  JAMA Oncology · 2021 · https://doi.org/10.1001/jamaoncol.2021.0379

• Progression-Free Survival: Meaningful or Simply Measurable?

  Journal of Clinical Oncology · 2012 · https://doi.org/10.1200/jco.2011.38.7571

• Definitions for Response and Progression in Ovarian Cancer Clinical Trials Incorporating RECIST 1.1 and CA 125 Agreed by the Gynecological Cancer Intergroup (GCIG)

  International Journal of Gynecological Cancer · 2011 · https://doi.org/10.1097/igc.0b013e3182070f17

• Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

  The Lancet Oncology · 2009 · https://doi.org/10.1016/s1470-2045(09)70025-7

• Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials

  Journal of Clinical Oncology · 2008 · https://doi.org/10.1200/jco.2007.12.7837

• Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3

  The Lancet Oncology · 2007 · https://doi.org/10.1016/s1470-2045(07)70384-4

• Gemcitabine Plus Carboplatin Compared With Carboplatin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer: An Intergroup Trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG

  Journal of Clinical Oncology · 2006 · https://doi.org/10.1200/jco.2006.06.0913

• Health-related quality of life in patients with glioblastoma: a randomised controlled trial

  The Lancet Oncology · 2005 · https://doi.org/10.1016/s1470-2045(05)70432-0

• New guidelines to evaluate the response to treatment in solid tumors

  Breast Cancer · 2005 · https://doi.org/10.1007/bf02967383

• Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma

  New England Journal of Medicine · 2005 · https://doi.org/10.1056/nejmoa043330

• Phase I Trial Design for Solid Tumor Studies of Targeted, Non-Cytotoxic Agents: Theory and Practice

  JNCI Journal of the National Cancer Institute · 2004 · https://doi.org/10.1093/jnci/djh182

• Re: New Guidelines to Evaluate the Response to Treatment in Solid Tumors (Ovarian Cancer)

  JNCI Journal of the National Cancer Institute · 2004 · https://doi.org/10.1093/jnci/djh081

• New Guidelines to Evaluate the Response to Treatment in Solid Tumors

  JNCI Journal of the National Cancer Institute · 2000 · https://doi.org/10.1093/jnci/92.3.205

Current projects

No projects listed.